Our Opinion

Longboard Pharmaceuticals Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“We believe there is a strong rationale for CB2 agonism in neurodegenerative diseases, given increased CB2 expression in patients with these diseases as well as results from animal models.” (Page 3) Read the full document

Company Description

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing medicines for neurological diseases. Its pipelines includes LP352, LP143 and LP659.

Company Website: https://www.longboardpharma.com